Search - tctmd.com

Displaying 681 - 700 of 2446

Sort: Relevancy | Date

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

Shelley Wood

January 03, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2022

Caitlin E. Cox

January 02, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

‘Digital Biomarker,’ Derived From EHR, Can Diagnose and Describe CAD

Yael L. Maxwell

December 27, 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Todd Neale

December 23, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

Todd Neale

December 21, 2022

News Daily News

Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance

L.A. McKeown

December 20, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

Advertisement

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Top Structural Heart News of 2022

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

TCTMD’s Top 10 Most Popular Stories for December 2022

Top Endovascular News of 2022

Top Policy and Practice News for Cardiologists in 2022

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

The Biggest News of 2022: TCTMD’s Top 10

December 2022 News Roundup

‘Digital Biomarker,’ Derived From EHR, Can Diagnose and Describe CAD

Top General Cardiology and Prevention News of 2022

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance

Reduction in BP Drives Treatment Preference for Hypertensive Patients

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content